News

Univeristy of Michigan neurologist, David Fink, MD, leads the team studying treatment for nerve damage related to diabetes and chemotherapy. They will join Diamyd Inc. in a project funded by the NIH to develop a new treatment for preventing nerve damage. “This is a case of ‘bench to bedside’ research,” Dr. Fink says. READ MORE